360 related articles for article (PubMed ID: 31820171)
1. The Microbiome and Its Potential for Pharmacology.
Chavira A; Belda-Ferre P; Kosciolek T; Ali F; Dorrestein PC; Knight R
Handb Exp Pharmacol; 2019; 260():301-326. PubMed ID: 31820171
[TBL] [Abstract][Full Text] [Related]
2. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
Doré J; Multon MC; Béhier JM;
Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
[TBL] [Abstract][Full Text] [Related]
3. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
[TBL] [Abstract][Full Text] [Related]
4. The Future of Microbiome-Based Therapeutics in Clinical Applications.
Sharma A; Das P; Buschmann M; Gilbert JA
Clin Pharmacol Ther; 2020 Jan; 107(1):123-128. PubMed ID: 31617205
[TBL] [Abstract][Full Text] [Related]
5. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer.
Rajpoot M; Sharma AK; Sharma A; Gupta GK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):1-8. PubMed ID: 29425888
[TBL] [Abstract][Full Text] [Related]
6. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
Khalsa J; Duffy LC; Riscuta G; Starke-Reed P; Hubbard VS
Clin Pharmacol Drug Dev; 2017 Mar; 6(2):176-185. PubMed ID: 28263462
[TBL] [Abstract][Full Text] [Related]
7. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
8. Host Microbiomes in Tumor Precision Medicine: How far are we?
D'Amico F; Barone M; Tavella T; Rampelli S; Brigidi P; Turroni S
Curr Med Chem; 2022; 29(18):3202-3230. PubMed ID: 34986765
[TBL] [Abstract][Full Text] [Related]
9. Human Microbiome and Learning Healthcare Systems: Integrating Research and Precision Medicine for Inflammatory Bowel Disease.
Chuong KH; Mack DR; Stintzi A; O'Doherty KC
OMICS; 2018 Feb; 22(2):119-126. PubMed ID: 28282257
[TBL] [Abstract][Full Text] [Related]
10. Approaching precision medicine by tailoring the microbiota.
Ryu G; Kim H; Koh A
Mamm Genome; 2021 Aug; 32(4):206-222. PubMed ID: 33646347
[TBL] [Abstract][Full Text] [Related]
11. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the microbiota for therapeutic purposes.
Liwinski T; Elinav E
Am J Transplant; 2020 Jun; 20(6):1482-1488. PubMed ID: 31858698
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
Carlucci C; Petrof EO; Allen-Vercoe E
EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396
[TBL] [Abstract][Full Text] [Related]
14. Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes.
Lam KN; Alexander M; Turnbaugh PJ
Cell Host Microbe; 2019 Jul; 26(1):22-34. PubMed ID: 31295421
[TBL] [Abstract][Full Text] [Related]
15. Interaction between drugs and the gut microbiome.
Weersma RK; Zhernakova A; Fu J
Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
[TBL] [Abstract][Full Text] [Related]
16. A clinician's primer on the role of the microbiome in human health and disease.
Khanna S; Tosh PK
Mayo Clin Proc; 2014 Jan; 89(1):107-14. PubMed ID: 24388028
[TBL] [Abstract][Full Text] [Related]
17. The microbiome and precision oncology: an emerging paradigm in anticancer therapy.
Bhat SA; Kaur R; Chauhan A; Pal A
Crit Rev Microbiol; 2022 Nov; 48(6):770-783. PubMed ID: 35164642
[TBL] [Abstract][Full Text] [Related]
18. The Cutaneous Microbiome: Implications for Dermatology Practice.
Sander MA; Sander MS; Isaac-Renton JL; Croxen MA
J Cutan Med Surg; 2019; 23(4):436-441. PubMed ID: 30938174
[TBL] [Abstract][Full Text] [Related]
19. Impacts of the Human Gut Microbiome on Therapeutics.
Vázquez-Baeza Y; Callewaert C; Debelius J; Hyde E; Marotz C; Morton JT; Swafford A; Vrbanac A; Dorrestein PC; Knight R
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():253-270. PubMed ID: 28968189
[TBL] [Abstract][Full Text] [Related]
20. Diet, Microbiome, and Epigenetics in the Era of Precision Medicine.
Riscuta G; Xi D; Pierre-Victor D; Starke-Reed P; Khalsa J; Duffy L
Methods Mol Biol; 2018; 1856():141-156. PubMed ID: 30178250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
